Skip to main content
. 2023 May 23;12(11):3625. doi: 10.3390/jcm12113625
COI conflict of interest
COVID-19 coronavirus disease 2019
DSS data sharing statement
FLV fluvoxamine
ITT intention-to-treat
IVM ivermectin
OR odds ratio
OTC over-the-counter
PP per-protocol
RCT randomized clinical trial
RR relative risk
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
SP spike protein
SpO2 peripheral oxygen saturation